New drug candidate offers hope for patients with NRAS-driven melanoma
A Huntsman Cancer Institute team at the University of Utah reports that daraxonrasib, a targeted RAS inhibitor, could offer a ...
A Huntsman Cancer Institute team at the University of Utah reports that daraxonrasib, a targeted RAS inhibitor, could offer a ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine